FKnol.com

Financial Knowledge & Information Portal

Zoetis (ZTS) Company Profile

Updated May 14, 2020
Zoetis has the following business profile:
Company's Full Name:Zoetis Inc.
Short Name:Zoetis
Trading Ticker Symbol:ZTS
Primary Exchange:NYSE
Headquarter City/Country:New Jersey, NJ
Primary Industry Sector:Health Care
Seconday Sub-sector:Major Pharmaceuticals
Main Business Areas: Health Care, Major Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Pharma, Healthcare, S&P 500
Dividend Payments:Dividend History
ETFs Holding:List of ETFs holding Zoetis stock

Market and Trading Information for Zoetis

The following details were available for trading and market data about the stock of Zoetis as of writing:
Current Share Price:$126.03
Previous Year's Closing Price:$132.35
Percentage Price Change (YTD):-4.78%
Market Cap:$59.86 billion
52-week Price Range:$90.14 - $146.26
Dividend Per Share:$0.69
EPS (TTM):3.34
Price-Earnings (Trailing):37.73
Price-Earnings (Forward):29.45

Company Profile and Business Description for Zoetis

Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. As of December 31, 2016, the Company had approximately 300 product lines, including products for both livestock and companion animals across each of its product categories. As of December 31, 2016, the Company marketed its products to veterinarians and livestock producers located in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America.

The Company's livestock products primarily help prevent or treat diseases. The Company's anti-infectives products prevent, kill or slow the growth of bacteria, fungi or protozoa. Its vaccines help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response. Its parasiticides products prevent or eliminate external and internal parasites such as fleas, ticks and worms. Its medicated feed additives are added to animal feed that provide medicines to livestock. Its other pharmaceutical products include pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. It offers other product categories, such as nutritionals and agribusiness, as well as products and services in various areas, including biodevices, diagnostics and genetics. The Company's portfolio includes diagnostics products such as the Witness line of immunodiagnostic kits. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Cydectin, Dectomax, Aureomycin, Lasalocid line, Lincomycin line, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, Vanguard line, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

The Company competes with Boehringer Ingelheim GmbH, Merck & Co., Inc., Eli Lilly and Company, and Bayer AG.

10 Sylvan Way

ETFs Holding Zoetis Stock

As of March 2020, the following exchange-traded funds (ETF) hold the Zoetis stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Zoetis stock holding. There are a total of 172 ETFs in Fknol.com records which are holding Zoetis stock in their portfolio. See Full List.

TickerNameShort DescriptionExpense
Ratio
No. of
Holdings
Dividend
Frequency
DFNDReality Shares DIVCON Dividend Defender ETFThe Reality Shares DIVCON Dividend Defender ETF tracks an index of dividend-paying US large-cap stocks that are likely to increase dividends, while shorting those that are unlikely to do so. At rebalance, the fund is 75% long, 25% short. ...Full Details1.38%74
Full List
Semi-Annually
ACIMSPDR MSCI ACWI IMI ETFThe SPDR MSCI ACWI IMI ETF tracks a market-cap-weighted index of global stocks covering 98% of the capitalization of the developed and emerging markets. ...Full Details0.25%906
Full List
Semi-Annually
ACWIiShares MSCI ACWI ETFThe iShares MSCI ACWI ETF tracks a market-cap-weighted index of large- and midcap global stocks, covering 85% of the developed and emerging markets capitalization. ...Full Details ...Candlestick Patterns.0.32%1596
Full List
Semi-Annually
BIBLInspire 100 ETFThe Inspire 100 ETF tracks a market-cap-weighted index of large-cap US stocks, selected based on the firm’s proprietary definition of biblical values. ...Full Details0.35%101
Full List
Quarterly
CACGClearBridge All Cap Growth ETFThe ClearBridge All Cap Growth ETF is an actively managed fund of global stocks and ADRs selected for above average long-term earnings and/or cash flow growth. ...Full Details0.53%87
Full List
Annually
CATHGlobal X S&P 500 Catholic Values ETFThe Global X S&P 500 Catholic Values ETF tracks an index of US large-cap stocks selected from the S&P 500. The cap-weighted index omits companies from certain industries at odds with Catholic values. ...Full Details0.29%464
Full List
Annually
CRBNiShares MSCI ACWI Low Carbon Target ETFThe iShares MSCI ACWI Low Carbon Target ETF tracks an index of stocks from global firms selected for a bias toward lower carbon emissions, but with tight constraints to the broad, marketlike ACWI index. ...Full Details0.2%1204
Full List
Semi-Annually
CSMProshares Large Cap Core PlusThe ProShares Large Cap Core Plus ETF tracks a long/short index of the 500 largest US stocks. It uses a set of rules to assign weights to each equity that add up to 130% long and 30% short exposure. ...Full Details0.45%320
Full List
Quarterly
DEFInvesco Defensive Equity ETFThe Invesco Defensive Equity ETF tracks an index that aims to outperform in down markets while maintaining upside potential. The equal-weighted index picks 100 US stocks using proprietary methods. ...Full Details0.6%101
Full List
Annually
DGROiShares Core Dividend Growth ETFThe iShares Core Dividend Growth ETF tracks an index of US stocks that are selected by dividends, dividend growth and payout ratio, then weighted by dividend dollars. ...Full Details0.08%449
Full List
Quarterly

See Full List of ETFs holding Zoetis stock in their respective portfolios.

Peer / Competitor Companies of Major Pharmaceuticals Sector

Along with Zoetis Inc., the following other peer (competitor) companies also exist within the same Major Pharmaceuticals - Health Care sector whose company profile and dividend history is as follows:

▶ Abbott Labs (ABT): Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ....See Detailed Company Profile,  Dividend History  and Recent Candlestick Patterns.

▶ AbbVie (ABBV): AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile,  Dividend History  and Recent Candlestick Patterns.

▶ Abeona Therapeutics (ABEO): Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile,  Dividend History

▶ AC Immune SA (ACIU): AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile,  Dividend History

▶ ACADIA Pharma (ACAD): ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile,  Dividend History

▶ Acasti Pharma (ACST): Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile,  Dividend History

▶ AcelRx Pharma (ACRX): AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile,  Dividend History

▶ Achillion Pharma (ACHN): Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ....See Detailed Company Profile,  Dividend History

▶ Aclaris Therapeutics (ACRS): Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile,  Dividend History

▶ Actinium Pharma (ATNM): Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile,  Dividend History

▶ Acura Pharma (ACUR): Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile,  Dividend History

▶ Adamas Pharma (ADMS): Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile,  Dividend History

▶ Adamis Pharma (ADMP): Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile,  Dividend History

▶ Aduro Biotech (ADRO): Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile,  Dividend History

▶ Advaxis (ADXS): Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile,  Dividend History

▶ Aeglea BioTherapeutics (AGLE): Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile,  Dividend History

▶ AEterna Zentaris (AEZS): Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ....See Detailed Company Profile,  Dividend History

▶ Affimed (AFMD): Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ....See Detailed Company Profile,  Dividend History

▶ Agile Therapeutics (AGRX): Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ....See Detailed Company Profile,  Dividend History

▶ Agios Pharma (AGIO): Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ....See Detailed Company Profile,  Dividend History

... See Full List of All Stocks of Major Pharmaceuticals Sector.

Stock List of Other Health Care Sub-sectors

▶ Stocks of Biotech Sector

▶ Stocks of Biotech Apparatus Sector

▶ Stocks of Biotech Diagnostics Sector

▶ Stocks of Biotech Products Sector

▶ Stocks of Biotech Research Sector

▶ Stocks of Biotechnology Sector

▶ Stocks of Diagnostics & Research Sector

▶ Stocks of Drug Delivery Sector

▶ Stocks of Drug Development Sector

▶ Stocks of Drug Manufacturer Sector

▶ Stocks of Drug Manufacturers—Specialty & Generic Sector

▶ Stocks of Health Care Sector

▶ Stocks of Health Care Equipment and Services Sector

▶ Stocks of Hospital and Nursing Management Sector

▶ Stocks of Industrial Specialties Sector

▶ Stocks of Major Pharmaceuticals Sector

▶ Stocks of Medical Care Facilities Sector

▶ Stocks of Medical Dental Instruments Sector

▶ Stocks of Medical Devices Sector

▶ Stocks of Medical Electronics Sector

▶ Stocks of Medical Instruments & Supplies Sector

▶ Stocks of Medical Nursing Services Sector

▶ Stocks of Medical Products Sector

▶ Stocks of Medical Specialities Sector

▶ Stocks of Ophthalmic Goods Sector

▶ Stocks of Other Pharmaceuticals Sector

▶ Stocks of Precision Instruments Sector


Stock List of Other Top-level Sectors

▶ Stocks of Sector

▶ Stocks of Basic Industries Sector

▶ Stocks of Basic Materials Sector

▶ Stocks of Capital Goods Sector

▶ Stocks of Communication Services Sector

▶ Stocks of Consumer Cyclical Sector

▶ Stocks of Consumer Defensive Sector

▶ Stocks of Consumer Discretionary Sector

▶ Stocks of Consumer Durables Sector

▶ Stocks of Consumer Non-Durables Sector

▶ Stocks of Consumer Services Sector

▶ Stocks of Energy Sector

▶ Stocks of Finance Sector

▶ Stocks of Financial Services Sector

▶ Stocks of Health Care Sector

▶ Stocks of Healthcare Sector

▶ Stocks of Industrials Sector

▶ Stocks of Miscellaneous Sector

▶ Stocks of Public Utilities Sector

▶ Stocks of Real Estate Sector

▶ Stocks of Services Sector

▶ Stocks of Technology Sector

▶ Stocks of Transportation Sector

▶ Stocks of Utilities Sector